Vitalhub Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Vitalhub wird ein Gewinn- und Umsatzwachstum von 111.9% bzw. 19.8% pro Jahr prognostiziert, während der Gewinn pro Aktie um 99.8% pro Jahr wachsen soll.

Wichtige Informationen

111.9%

Wachstumsrate der Gewinne

99.8%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum	32.3%
Wachstumsrate der Einnahmen	19.8%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Good
Zuletzt aktualisiert	03 Dec 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Vitalhub's (TSE:VHI) Performance Is Even Better Than Its Earnings Suggest

Aug 15

Vitalhub Corp. (TSE:VHI) Soars 25% But It's A Story Of Risk Vs Reward

Aug 11

After Leaping 27% Vitalhub Corp. (TSE:VHI) Shares Are Not Flying Under The Radar

Feb 06

If EPS Growth Is Important To You, Vitalhub (TSE:VHI) Presents An Opportunity

Jan 27

Vitalhub Corp.'s (TSE:VHI) P/E Is Still On The Mark Following 40% Share Price Bounce

Nov 24

Shareholders Will Be Pleased With The Quality of Vitalhub's (TSE:VHI) Earnings

Nov 16

Is Vitalhub (TSE:VHI) A Risky Investment?

Dec 22

Brokers Are Upgrading Their Views On Vitalhub Corp. (TSE:VHI) With These New Forecasts

Apr 28

Are Investors Undervaluing Vitalhub Corp. (CVE:VHI) By 40%?

Aug 24

Here's Why Shareholders May Want To Be Cautious With Increasing Vitalhub Corp.'s (CVE:VHI) CEO Pay Packet

Jun 29

Vitalhub Corp.'s (CVE:VHI) Intrinsic Value Is Potentially 48% Above Its Share Price

May 18

Is Vitalhub Corp. (CVE:VHI) Potentially Undervalued?

Apr 01

Loss-Making Vitalhub Corp. (CVE:VHI) Set To Breakeven

Feb 16

Does Vitalhub's (CVE:VHI) Share Price Gain of 49% Match Its Business Performance?

Dec 24

An Intrinsic Calculation For Vitalhub Corp. (CVE:VHI) Suggests It's 40% Undervalued

Nov 19

Gewinn- und Umsatzwachstumsprognosen

TSX:VHI - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CAD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	93	N/A	35	N/A	3
12/31/2025	86	12	27	26	7
12/31/2024	67	4	15	19	7
9/30/2024	62	3	21	22	N/A
6/30/2024	58	5	18	18	N/A
3/31/2024	55	6	20	21	N/A
12/31/2023	53	5	20	20	N/A
9/30/2023	50	3	13	14	N/A
6/30/2023	47	0	7	8	N/A
3/31/2023	43	0	4	4	N/A
12/31/2022	40	1	6	6	N/A
9/30/2022	36	1	8	9	N/A
6/30/2022	32	0	5	5	N/A
3/31/2022	29	0	4	4	N/A
12/31/2021	25	-2	0	0	N/A
9/30/2021	23	-2	0	1	N/A
6/30/2021	19	-3	2	3	N/A
3/31/2021	16	-2	1	1	N/A
12/31/2020	14	-2	0	0	N/A
9/30/2020	11	-1	0	0	N/A
6/30/2020	10	-1	-1	-1	N/A
3/31/2020	11	-1	0	0	N/A
12/31/2019	10	-1	0	0	N/A
9/30/2019	10	-1	-1	-1	N/A
6/30/2019	10	-1	-1	-1	N/A
3/31/2019	9	-1	-2	-2	N/A
12/31/2018	9	-1	-2	-2	N/A
9/30/2018	8	-2	-1	-1	N/A
6/30/2018	6	-2	N/A	-1	N/A
3/31/2018	4	-2	N/A	-2	N/A
12/31/2017	1	-2	N/A	-1	N/A
9/30/2017	1	-2	N/A	-2	N/A
6/30/2017	1	-2	N/A	-1	N/A
3/31/2017	0	-2	N/A	-1	N/A
12/31/2016	0	-1	N/A	-1	N/A
9/30/2016	0	-2	N/A	-1	N/A
6/30/2016	0	-2	N/A	-1	N/A
3/31/2016	1	-2	N/A	-1	N/A
12/31/2015	1	-2	N/A	-1	N/A
12/31/2014	0	-2	N/A	-1	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: VHIDas prognostizierte Gewinnwachstum (111.9% pro Jahr) liegt über der Sparquote (2.3%).

Ertrag vs. Markt: VHIDie Erträge des Unternehmens (111.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (15.4% pro Jahr).

Hohe Wachstumserträge: VHIEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: VHIDie Einnahmen des Unternehmens (19.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (7.3% pro Jahr).

Hohe Wachstumseinnahmen: VHIDie Einnahmen des Unternehmens (19.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von VHI in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2024/12/20 12:52
Aktienkurs zum Tagesende	2024/12/20 00:00
Gewinne	2024/09/30
Jährliche Einnahmen	2023/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

^* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie hier mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf .

Analysten-Quellen

Vitalhub Corp. wird von 9 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
Gabriel Leung	Beacon Securities Limited
Douglas Taylor	Canaccord Genuity
Gavin Fairweather	Cormark Securities Inc.

Vitalhub Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 13%, revenue upgraded

Price target increased by 7.8% to CA$10.96

Consensus EPS estimates fall by 33%, revenue upgraded

Price target increased by 13% to CA$9.29

Consensus EPS estimates fall by 11%, revenue upgraded

Price target increased by 8.5% to CA$6.92

Recent updates

Vitalhub Corp. has filed a Follow-on Equity Offering in the amount of CAD 30.00007 million.

Consensus EPS estimates fall by 13%, revenue upgraded

Third quarter 2024 earnings: EPS misses analyst expectations

Vitalhub Corp. to Report Q3, 2024 Results on Nov 13, 2024

Price target increased by 7.8% to CA$10.96

Vitalhub Corp. (TSX:VHI) acquired Strata Health Solutions Inc for CAD 36.8 million.

Vitalhub Corp. (TSX:VHI) completed the acquisition of MedCurrent Corporation for CAD 33.9 million

Consensus EPS estimates fall by 33%, revenue upgraded

Vitalhub's (TSE:VHI) Performance Is Even Better Than Its Earnings Suggest

Price target increased by 13% to CA$9.29

Vitalhub Corp. (TSE:VHI) Soars 25% But It's A Story Of Risk Vs Reward

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. (TSX:VHI) agreed to acquire MedCurrent Corporation for CAD 33.9 million.

Vitalhub Corp. to Report Q2, 2024 Results on Aug 08, 2024

Consensus EPS estimates fall by 11%, revenue upgraded

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Vitalhub Corp. to Report Q1, 2024 Results on May 09, 2024

Insufficient new directors

Vitalhub Corp. Announces Executive Promotions

Chairman of the Board recently bought CA$1.5m worth of stock

New minor risk - Shareholder dilution

Vitalhub Corp., Annual General Meeting, Jun 27, 2024

Vitalhub Corp. has completed a Follow-on Equity Offering in the amount of CAD 40.254 million.

Vitalhub Corp. has filed a Follow-on Equity Offering in the amount of CAD 35.004 million.

Price target increased by 8.5% to CA$6.92

Full year 2023 earnings: EPS misses analyst expectations

Vitalhub Corp. to Report Q4, 2023 Results on Mar 21, 2024

Price target increased by 11% to CA$6.04

Investor sentiment improves as stock rises 18%

After Leaping 27% Vitalhub Corp. (TSE:VHI) Shares Are Not Flying Under The Radar

Vitalhub Corp. (TSX:VHI) acquired Bookwise Solutions Limited.

If EPS Growth Is Important To You, Vitalhub (TSE:VHI) Presents An Opportunity

Vitalhub Corp.'s (TSE:VHI) P/E Is Still On The Mark Following 40% Share Price Bounce

Shareholders Will Be Pleased With The Quality of Vitalhub's (TSE:VHI) Earnings

Consensus EPS estimates increase by 44%

Investor sentiment improves as stock rises 20%

Price target increased by 8.5% to CA$5.33

Vitalhub Corp. Announces Board Changes

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Vitalhub Corp. to Report Q3, 2023 Results on Nov 09, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q2, 2023 Results on Aug 10, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q1, 2023 Results on May 12, 2023

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. (TSX:VHI) acquired Coyote Software Corporation for CAD 2.37 million.

Is Vitalhub (TSE:VHI) A Risky Investment?

Insufficient new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Vitalhub Corp. (TSX:VHI) acquired assets to maintain the business of Advanced Digital Innovation.

Vitalhub Corp. to Report Q3, 2022 Results on Nov 10, 2022

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q2, 2022 Results on Aug 11, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Vitalhub Corp. to Report Q1, 2022 Results on May 12, 2022

Brokers Are Upgrading Their Views On Vitalhub Corp. (TSE:VHI) With These New Forecasts

Vitalhub Corp., Annual General Meeting, Jun 29, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Director recently bought CA$291k worth of stock

Third quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.039 loss in 3Q 2020)

Vitalhub Corp.(TSXV:VHI) dropped from S&P/TSX Venture Composite Index

Second quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.007 profit in 2Q 2020)

Are Investors Undervaluing Vitalhub Corp. (CVE:VHI) By 40%?

Here's Why Shareholders May Want To Be Cautious With Increasing Vitalhub Corp.'s (CVE:VHI) CEO Pay Packet

First quarter 2021 earnings released: CA$0.007 loss per share (vs CA$0.029 loss in 1Q 2020)

Vitalhub Corp. (TSXV:VHI) completed the acquisition of Assets of On-premises Acute (hospital) queue management business of Jayex Healthcare Limited (ASX:JHL).

Vitalhub Corp.'s (CVE:VHI) Intrinsic Value Is Potentially 48% Above Its Share Price

President exercised options to buy CA$216k worth of stock.